Charles Knirsch - Concepedia

Author

Charles Knirsch

Also Known As

Aaron S Kesselheim, Bing Cai, C A Knirsch, C Knirsch, C. A. Knirsch, C. Knirsch, CHARLES A. KNIRSCH, CHARLES KNIRSCH, Carlo Giaquinto, Charles A Knirsch

Publications

6.7K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Columbia University New York City Department of Health and Mental Hygiene Columbia University Irving Medical Center Armed Forces Research Institute of Medical Science

About

Charles Knirsch is an author at Pfizer (United States) specializing in medicine, antimicrobial resistance, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.1K
2	Engineering	5	5	284
3	Public Health	5	5	289
4	Health Sciences	4	4	350
5	Nursing	2	2	53

Charles Knirsch

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections John A. Weigelt, Kamal Itani, Dennis L. Stevens, Antimicrobial Agents and Chemotherapy	2005	450
Azithromycin for the Secondary Prevention of Coronary Events J. Thomas Grayston, Richard A. Kronmal, Lisa A. Jackson, New England Journal of Medicine	2005	374
Nonadherence in Tuberculosis Treatment: Predictors and Consequences in New York City Ariel Pablos-Méndez, Charles Knirsch, R. Graham Barr, The American Journal of Medicine	1997	252
Complicated Skin and Skin‐Structure Infections and Catheter‐Related Bloodstream Infections: Noninferiority of Linezolid in a Phase 3 Study Mark H. Wilcox, Kenneth J. Tack, Emilio Bouza, Clinical Infectious Diseases	2008	216
The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Ariel Pablos-Méndez, Jeffrey Blustein, Charles Knirsch American Journal of Public Health	1997	192
Discontinuation of <i>Mycobacterium avium</i> Complex Prophylaxis in Patients with Antiretroviral Therapy–Induced Increases in CD4+ Cell Count Judith S. Currier, Paige L. Williams, Susan L. Koletar, Annals of Internal Medicine	2000	133
Azithromycin Found to Be Comparable to Levofloxacin for the Treatment of US Travelers with Acute Diarrhea Acquired in Mexico Javier A. Adachi, C. D. Ericsson, Z.-D. Jiang, Clinical Infectious Diseases Receiving AzithromycinHealth SciencesAntibioticsPharmacologyGastroenterology	2003	131
Neighborhood Poverty and the Resurgence of Tuberculosis in New York City, 1984–1992 R. Graham Barr, Ana V. Diez–Roux, Charles Knirsch, American Journal of Public Health Neighborhood PovertyUrban HealthPopulation PovertyNew York CityHealth Disparities	2001	129
Assessment of Azithromycin in Combination with Other Antimalarial Drugs against <i>Plasmodium falciparum</i> In Vitro Colin Ohrt, George D. Willingmyre, Patricia Lee, Antimicrobial Agents and Chemotherapy Chloroquine-azithromycin CombinationAntibioticsAntiparasitic AgentMalaria ProphylaxisMalaria	2002	128
A comprehensive regulatory framework to address the unmet need for new antibacterial treatments John Rex, Barry I. Eisenstein, Jeff Alder, The Lancet Infectious Diseases Antimicrobial SusceptibilityNew Antibacterial TreatmentsAntibioticsUnmet NeedComprehensive Regulatory Framework	2013	119

Page 1